Patent 8741887 was granted and assigned to Janssen Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: